FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19
PALM BEACH, Fla., Jan. 21, 2021 /PRNewswire/ Most of the news on advances for Covid-19 tend to focus on vaccines, however treatments are just as important. While vaccines can stop people from contracting Covid and becoming seriously ill, treatments will still be needed for those who already have it. Having an effective treatment would, in essence, make coronavirus a milder disease. If it stopped people who were admitted to hospital from needing ventilation, then there would be less risk of intensive care units in hospitals being overwhelmed. An article in the BBC said that there are three broad approaches being investigated: Antiviral drugs that directly affect the coronavirus s ability to thrive inside the body; Drugs that calm the immune system (severe Covid-19 is caused by patients immune systems overreacting and damaging the body); and Antibodies that can target the virus, taken from either survivors blood plasma